Investor

S.R. One , Limited

Last cheque observed Jun 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries ASeries C

Cheques on record
0%of best year0cheques in 12 months, 10 on record
Since the last cheque4136days00hrs00min00sec
Median round$23MRounds led0 of 10Sole investor1 roundsExits5 from the portfolioMostly inUnited States, 100%
Pitch S.R. One , Limited

S.R. One , Limited highlights

  1. 01

    10 rounds on record

  2. 02

    Mostly Series B and Series A: 50% of its rounds

  3. 03

    Sole investor in 1 rounds, median $2.0M

  4. 04

    5 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first10 appearances

  1. 2015

    1 round

  2. Jun
    Avhana HealthSeed · US$750KWith 4 others
  3. 2007

    1 round

  4. Feb
    Locus PharmaceuticalsSeries E · US$30MWith 3 others
  5. 2005

    2 rounds

  6. Aug
    Protez PharmaceuticalsSeries B$15MWith 3 others
  7. Jan
    Predix PharmaceuticalsSeries C$43MWith 10 others
  8. 2004

    1 round

  9. Feb
    MorphotekSeries C · US$26MWith 9 others
  10. 2003

    4 rounds

  11. Dec
    LinguagenSeries A · US$2.0MSole investor
  12. Nov
    Protein ForestSeries A · US$19MWith 3 others
  13. May
    SantarusSeries D · US$51MWith 9 others
  14. Mar
    HypnionSeries B · US$48MWith 8 others
  15. 2002

    1 round

  16. Nov
    NeuroGenetic PharmaceuticalsSeries B · US$10MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed5 in all

SantarusBought by Salix Pharmaceuticals$2.6BNov 2013
Protein ForestBought by CellBiosciencesUndisclosedDec 2009
Protez PharmaceuticalsBought by Novartis$400MJun 2008
HypnionBought by LillyUndisclosedApr 2007
SantarusListedUndisclosedApr 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as S.R. One , Limited. A count of rooms they were both in, not a relationship either has claimed.

Boston Millennia PartnersPrivate equity3rounds togetherForward VenturesAccelerator3rounds togetherChina Development Industrial Bank (CDIB)Growth equity2rounds togetherFlagship VenturesAccelerator2rounds togetherL Capital PartnersVC firm2rounds together

Quick answers about S.R. One , Limited

What does S.R. One , Limited invest in?

S.R. One , Limited invests most often at Series B and Series A (50% of the rounds on record).

How active is S.R. One , Limited?

10 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2015.

How big are S.R. One , Limited's cheques?

The median round it joins is $23M.

Does S.R. One , Limited lead rounds?

Rarely, if at all: none of its 10 investments on record names it as the lead.

Where does S.R. One , Limited invest?

Most of the companies it backs are in the United States (100%).

Is S.R. One , Limited investing now?

No investments in the last 12 months; the latest was in Jun 2015.

Who does S.R. One , Limited invest alongside?

Most often Boston Millennia Partners (3 rounds together), Forward Ventures (3 rounds together) and China Development Industrial Bank (CDIB) (2 rounds together).

What kind of investor is S.R. One , Limited?

S.R. One , Limited is a growth equity firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it